ANIK logo

Anika Therapeutics (ANIK) Cash From Investing

Annual CFI

-$5.43 M
+$2.06 M+27.50%

December 31, 2023


Summary


Performance

ANIK Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANIKcash flowmetrics:

Quarterly CFI

-$1.82 M
+$1.59 M+46.64%

September 30, 2024


Summary


Performance

ANIK Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANIKcash flowmetrics:

TTM CFI

-$8.87 M
-$1.07 M-13.80%

September 30, 2024


Summary


Performance

ANIK TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANIKcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ANIK Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+27.5%0.0%0.0%
3 y3 years+92.4%-40.2%-159.4%
5 y5 years+89.2%-186.5%-122.3%

ANIK Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-74.0%+27.5%-145.1%+46.6%-184.4%at low
5 y5-year-113.7%+92.4%-104.4%+98.0%-122.3%+87.6%
alltimeall time-113.7%+92.4%-104.4%+98.0%-122.3%+87.6%

Anika Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.82 M(-46.6%)
-$8.87 M(+13.8%)
Jun 2024
-
-$3.40 M(+88.2%)
-$7.79 M(+33.3%)
Mar 2024
-
-$1.81 M(-1.7%)
-$5.85 M(+7.7%)
Dec 2023
-$5.43 M(-27.5%)
-$1.84 M(+148.3%)
-$5.43 M(-11.3%)
Sep 2023
-
-$741.00 K(-49.1%)
-$6.12 M(-13.4%)
Jun 2023
-
-$1.46 M(+4.9%)
-$7.07 M(-6.4%)
Mar 2023
-
-$1.39 M(-45.1%)
-$7.55 M(+0.8%)
Dec 2022
-$7.49 M(+140.1%)
-$2.53 M(+49.6%)
-$7.49 M(+20.8%)
Sep 2022
-
-$1.69 M(-12.8%)
-$6.20 M(+6.8%)
Jun 2022
-
-$1.94 M(+46.3%)
-$5.80 M(-6.1%)
Mar 2022
-
-$1.33 M(+6.9%)
-$6.18 M(+98.1%)
Dec 2021
-$3.12 M(-95.6%)
-$1.24 M(-4.2%)
-$3.12 M(-120.9%)
Sep 2021
-
-$1.29 M(-44.1%)
$14.93 M(-35.0%)
Jun 2021
-
-$2.32 M(-233.6%)
$22.95 M(-0.1%)
Mar 2021
-
$1.73 M(-89.7%)
$22.97 M(-132.2%)
Dec 2020
-$71.26 M(-279.5%)
$16.81 M(+149.8%)
-$71.26 M(+51.5%)
Sep 2020
-
$6.73 M(-392.7%)
-$47.05 M(-9.0%)
Jun 2020
-
-$2.30 M(-97.5%)
-$51.68 M(+1.5%)
Mar 2020
-
-$92.50 M(-325.5%)
-$50.90 M(-228.2%)
Dec 2019
$39.69 M(-179.0%)
$41.02 M(+1853.5%)
$39.69 M(-1114.1%)
Sep 2019
-
$2.10 M(-238.5%)
-$3.91 M(-93.6%)
Jun 2019
-
-$1.52 M(-20.9%)
-$61.16 M(+16.8%)
Mar 2019
-
-$1.92 M(-25.7%)
-$52.38 M(+4.2%)
Dec 2018
-$50.26 M(+302.7%)
-$2.58 M(-95.3%)
-$50.26 M(+3.8%)
Sep 2018
-
-$55.14 M(-859.5%)
-$48.40 M(-1521.9%)
Jun 2018
-
$7.26 M(+3407.2%)
$3.40 M(-128.7%)
Mar 2018
-
$207.00 K(-128.6%)
-$11.85 M(-5.1%)
Dec 2017
-$12.48 M(+84.5%)
-$724.00 K(-78.3%)
-$12.48 M(+9.4%)
Sep 2017
-
-$3.34 M(-58.2%)
-$11.41 M(+8.0%)
Jun 2017
-
-$7.99 M(+1780.5%)
-$10.56 M(+91.3%)
Mar 2017
-
-$425.00 K(-223.2%)
-$5.52 M(-18.4%)
Dec 2016
-$6.76 M(-77.6%)
$345.00 K(-113.9%)
-$6.76 M(-66.3%)
Sep 2016
-
-$2.49 M(-15.6%)
-$20.05 M(-8.6%)
Jun 2016
-
-$2.95 M(+77.0%)
-$21.94 M(-15.2%)
Mar 2016
-
-$1.67 M(-87.1%)
-$25.89 M(-14.4%)
Dec 2015
-$30.23 M(+264.0%)
-$12.94 M(+195.1%)
-$30.23 M(+547.1%)
Sep 2015
-
-$4.38 M(-36.4%)
-$4.67 M(-77.2%)
Jun 2015
-
-$6.90 M(+14.8%)
-$20.53 M(+46.3%)
Mar 2015
-
-$6.01 M(-147.6%)
-$14.03 M(+69.0%)
Dec 2014
-$8.30 M(+3181.8%)
$12.62 M(-162.3%)
-$8.30 M(-61.3%)
Sep 2014
-
-$20.24 M(+4950.4%)
-$21.47 M(+1911.4%)
Jun 2014
-
-$400.80 K(+45.0%)
-$1.07 M(+69.6%)
Mar 2014
-
-$276.50 K(-49.6%)
-$629.40 K(+148.7%)
Dec 2013
-$253.00 K(-83.2%)
-$548.10 K(-446.7%)
-$253.10 K(-405.7%)
Sep 2013
-
$158.10 K(+326.1%)
$82.80 K(-137.2%)
Jun 2013
-
$37.10 K(-62.8%)
-$222.30 K(-81.2%)
Mar 2013
-
$99.80 K(-147.0%)
-$1.18 M(-21.5%)
Dec 2012
-$1.50 M(+7.5%)
-$212.20 K(+44.4%)
-$1.50 M(-13.5%)
Sep 2012
-
-$147.00 K(-84.0%)
-$1.74 M(-8.0%)
Jun 2012
-
-$921.40 K(+311.2%)
-$1.89 M(+22.1%)
Mar 2012
-
-$224.10 K(-49.8%)
-$1.55 M(+10.5%)
Dec 2011
-$1.40 M(-47.7%)
-$446.40 K(+49.7%)
-$1.40 M(-27.1%)
Sep 2011
-
-$298.20 K(-48.5%)
-$1.92 M(-20.9%)
Jun 2011
-
-$579.20 K(+656.1%)
-$2.43 M(+23.2%)
Mar 2011
-
-$76.60 K(-92.1%)
-$1.97 M(-26.5%)
Dec 2010
-$2.68 M(-86.7%)
-$967.30 K(+20.1%)
-$2.68 M(-85.5%)
Sep 2010
-
-$805.40 K(+562.9%)
-$18.52 M(-0.2%)
Jun 2010
-
-$121.50 K(-84.5%)
-$18.56 M(-6.0%)
Mar 2010
-
-$785.50 K(-95.3%)
-$19.73 M(-2.4%)
Dec 2009
-$20.22 M(+57.9%)
-$16.81 M(+1889.0%)
-$20.22 M(+317.6%)
Sep 2009
-
-$845.00 K(-34.9%)
-$4.84 M(-33.4%)
Jun 2009
-
-$1.30 M(+2.3%)
-$7.26 M(-48.2%)
Mar 2009
-
-$1.27 M(-11.3%)
-$14.02 M(+9.5%)
DateAnnualQuarterlyTTM
Dec 2008
-$12.80 M(-30.0%)
-$1.43 M(-56.2%)
-$12.80 M(-35.6%)
Sep 2008
-
-$3.27 M(-59.4%)
-$19.90 M(-0.8%)
Jun 2008
-
-$8.05 M(>+9900.0%)
-$20.06 M(+41.7%)
Mar 2008
-
-$55.30 K(-99.4%)
-$14.16 M(-22.6%)
Dec 2007
-$18.28 M(+1300.1%)
-$8.52 M(+148.2%)
-$18.28 M(+84.6%)
Sep 2007
-
-$3.43 M(+60.1%)
-$9.90 M(+50.0%)
Jun 2007
-
-$2.14 M(-48.7%)
-$6.60 M(+28.9%)
Mar 2007
-
-$4.18 M(+2828.4%)
-$5.12 M(+292.2%)
Dec 2006
-$1.31 M(-18.4%)
-$142.80 K(+9.0%)
-$1.31 M(-22.2%)
Sep 2006
-
-$131.00 K(-80.3%)
-$1.68 M(-27.2%)
Jun 2006
-
-$665.80 K(+81.8%)
-$2.31 M(+21.3%)
Mar 2006
-
-$366.30 K(-29.0%)
-$1.90 M(+18.8%)
Dec 2005
-$1.60 M(-564.9%)
-$516.10 K(-32.0%)
-$1.60 M(+40.6%)
Sep 2005
-
-$758.60 K(+191.0%)
-$1.14 M(+99.1%)
Jun 2005
-
-$260.70 K(+299.2%)
-$571.70 K(+958.7%)
Mar 2005
-
-$65.30 K(+21.6%)
-$54.00 K(-115.7%)
Dec 2004
$344.30 K(-76.8%)
-$53.70 K(-72.0%)
$344.30 K(-234.0%)
Sep 2004
-
-$192.00 K(-174.7%)
-$257.00 K(-12.0%)
Jun 2004
-
$257.00 K(-22.8%)
-$292.00 K(-115.3%)
Mar 2004
-
$333.00 K(-150.8%)
$1.91 M(+28.9%)
Dec 2003
$1.49 M(-7.5%)
-$655.00 K(+188.5%)
$1.49 M(-67.4%)
Sep 2003
-
-$227.00 K(-109.2%)
$4.56 M(+2.7%)
Jun 2003
-
$2.46 M(-2665.6%)
$4.44 M(-1043.6%)
Mar 2003
-
-$96.00 K(-104.0%)
-$470.50 K(-129.3%)
Dec 2002
$1.60 M(-68.6%)
$2.42 M(-798.5%)
$1.60 M(-273.8%)
Sep 2002
-
-$346.30 K(-85.8%)
-$923.30 K(-134.9%)
Jun 2002
-
-$2.45 M(-223.6%)
$2.65 M(-65.2%)
Mar 2002
-
$1.98 M(-1911.1%)
$7.61 M(+48.8%)
Dec 2001
$5.11 M(+61.4%)
-$109.30 K(-103.4%)
$5.11 M(-30.7%)
Sep 2001
-
$3.23 M(+28.4%)
$7.38 M(+34.6%)
Jun 2001
-
$2.51 M(-588.7%)
$5.49 M(-2292.4%)
Mar 2001
-
-$513.90 K(-123.8%)
-$250.20 K(-107.9%)
Dec 2000
$3.17 M(-186.8%)
$2.16 M(+62.8%)
$3.17 M(-48.5%)
Sep 2000
-
$1.33 M(-141.2%)
$6.16 M(+879.0%)
Jun 2000
-
-$3.22 M(-211.0%)
$628.80 K(-83.2%)
Mar 2000
-
$2.90 M(-43.6%)
$3.75 M(-202.8%)
Dec 1999
-$3.65 M(-74.6%)
$5.15 M(-222.6%)
-$3.65 M(-62.0%)
Sep 1999
-
-$4.20 M(+4100.0%)
-$9.60 M(-44.8%)
Jun 1999
-
-$100.00 K(-97.8%)
-$17.40 M(-4.9%)
Mar 1999
-
-$4.50 M(+462.5%)
-$18.30 M(+27.1%)
Dec 1998
-$14.40 M(+3500.0%)
-$800.00 K(-93.3%)
-$14.40 M(+2.9%)
Sep 1998
-
-$12.00 M(+1100.0%)
-$14.00 M(+600.0%)
Jun 1998
-
-$1.00 M(+66.7%)
-$2.00 M(+100.0%)
Mar 1998
-
-$600.00 K(+50.0%)
-$1.00 M(+150.0%)
Dec 1997
-$400.00 K(+300.0%)
-$400.00 K(<-9900.0%)
-$400.00 K(<-9900.0%)
Sep 1997
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 1997
-
$0.00(0.0%)
-$100.00 K(0.0%)
Mar 1997
-
$0.00(0.0%)
-$100.00 K(-50.0%)
Dec 1996
-$100.00 K(-75.0%)
-
-
Nov 1996
-
$0.00(-100.0%)
-$200.00 K(-50.0%)
Aug 1996
-
-$100.00 K(<-9900.0%)
-$400.00 K(-20.0%)
Aug 1996
-$400.00 K(+33.3%)
-
-
May 1996
-
$0.00(-100.0%)
-$500.00 K(-16.7%)
Feb 1996
-
-$100.00 K(-50.0%)
-$600.00 K(+20.0%)
Nov 1995
-
-$200.00 K(0.0%)
-$500.00 K(+66.7%)
Aug 1995
-$300.00 K(+50.0%)
-$200.00 K(+100.0%)
-$300.00 K(+50.0%)
May 1995
-
-$100.00 K(<-9900.0%)
-$200.00 K(+100.0%)
Feb 1995
-
$0.00(0.0%)
-$100.00 K(0.0%)
Nov 1994
-
$0.00(-100.0%)
-$100.00 K(-50.0%)
Aug 1994
-$200.00 K(-85.7%)
-$100.00 K(<-9900.0%)
-$200.00 K(+100.0%)
May 1994
-
$0.00(0.0%)
-$100.00 K(0.0%)
Feb 1994
-
$0.00(-100.0%)
-$100.00 K(0.0%)
Nov 1993
-
-$100.00 K
-$100.00 K
Aug 1993
-$1.40 M
-
-

FAQ

  • What is Anika Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Anika Therapeutics?
  • What is Anika Therapeutics annual CFI year-on-year change?
  • What is Anika Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Anika Therapeutics?
  • What is Anika Therapeutics quarterly CFI year-on-year change?
  • What is Anika Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Anika Therapeutics?
  • What is Anika Therapeutics TTM CFI year-on-year change?

What is Anika Therapeutics annual cash flow from investing activities?

The current annual CFI of ANIK is -$5.43 M

What is the all time high annual CFI for Anika Therapeutics?

Anika Therapeutics all-time high annual cash flow from investing activities is $39.69 M

What is Anika Therapeutics annual CFI year-on-year change?

Over the past year, ANIK annual cash flow from investing activities has changed by +$2.06 M (+27.50%)

What is Anika Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of ANIK is -$1.82 M

What is the all time high quarterly CFI for Anika Therapeutics?

Anika Therapeutics all-time high quarterly cash flow from investing activities is $41.02 M

What is Anika Therapeutics quarterly CFI year-on-year change?

Over the past year, ANIK quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is Anika Therapeutics TTM cash flow from investing activities?

The current TTM CFI of ANIK is -$8.87 M

What is the all time high TTM CFI for Anika Therapeutics?

Anika Therapeutics all-time high TTM cash flow from investing activities is $39.69 M

What is Anika Therapeutics TTM CFI year-on-year change?

Over the past year, ANIK TTM cash flow from investing activities has changed by $0.00 (0.00%)